Cours Cyteir Therapeutics, Inc.
Actions
CYTT
US23284P1030
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
-0,02 % | 42,11 Md | |
+43,29 % | 40,08 Md | |
+5,04 % | 40 Md | |
-11,32 % | 26,87 Md | |
+5,25 % | 24,58 Md | |
-23,83 % | 18,44 Md | |
-1,62 % | 11,94 Md | |
+22,75 % | 11,66 Md | |
+6,44 % | 11,01 Md |